Chugai Pharmaceutical Co., Ltd. and Cheplapharm K.K. announced that Chugai will transfer the business in Japan concerning the anti-cancer agent Tarceva tablets 25, 100, and 150 to Cheplapharm. Chugai ...

Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company, announces that the Scottish Medicines Consortium (SMC) has published recommendations that Agamree (vamorolone) is accepted for use ...

Takeda, a global leader in biopharmaceutical innovation, has inaugurated its flagship Global Innovation Capability Centre (ICC). The Takeda India ICC is a part of Takeda’s Data, Digital & Technology ...

The Indian Parliament had passed the Jan Vishwas (Amendment of Provisions) Bill, 2023 to remove stringent punishments such as imprisonment from some of the provisions of the Drugs and Cosmetics Act, ...

New findings from the National Institutes of Health’s (NIH) Researching Covid to Enhance Recovery (RECOVER) Initiative suggest that infection with SARS-CoV-2, the virus that causes Covid-19, may be ...

AKCDA president AN Mohan to get Kerala IPA’s Lifetime Achievement Award from Justice N Nagaresh tomorrow: Our Bureau, Chennai ...

Illumina, Inc., a global leader in genomic sequencing and analysis, announced it is collaborating with NVIDIA to advance technology platforms for the analysis and interpretation of multiomic data, ...

REGENXBIO Inc., a leading clinical-stage biotechnology company, and Nippon Shinyaku Co., Ltd. (Nippon Shinyaku) announced a strategic partnership for the development and commercialization of RGX-121 ...

Deep tech startup United We Care (UWC) announced the launch of United-MedASR, an advanced Medical Automatic Speech Recognition (ASR) model, which sets new global benchmarks for clinical accuracy. The ...

The Assam Small Scale Pharmaceutical Manufacturers Association (ASSPMA) has informed the Union health ministry that if the pharma manufacturing units in Guwahati are not provided with sufficient time ...

The Parliamentary Standing Committee on Chemicals and Fertilisers has criticised the ministry for its lack of interest in supporting the in-vitro diagnostic (IVD) devices production in the country ...

Regeneron Pharmaceuticals, Inc. announced positive results from the phase 3 C-POST trial, which demonstrated that adjuvant treatment with PD-1 inhibitor Libtayo (cemiplimab) led to a statistically ...